Intellectual Property & Technology

Biotechnology/Life Sciences

Stites and Harbison's Biotechnology/Life Sciences Law Group includes highly experienced and dedicated attorneys focused on intellectual property protection of all aspects of biotechnology and life sciences. These include genetic engineering, immunology, monoclonal antibodies, medical devices, diagnostics, therapeutics, genetic markers, and pharmaceuticals.

The Intellectual Property (IP) members of the Biotechnology/Life Sciences Law Group have extensive backgrounds in biotechnology and related fields, including work in research laboratories, experience with Patent Examination for the USPTO, and advanced degrees, and/or technical experience in fields such as microbiology and immunology, biology, and pharmacology and cell biophysics.

Our Biotechnology/Life Sciences Technology attorneys represent a full range of clients in the biotechnological arts, ranging from major companies and universities through a number of smaller start-up businesses.

In addition to patent prosecution, the Biotechnology/Life Sciences group counsels clients on all matters relating to domestic and international intellectual property issues. This includes issues relating to infringement, validity, and freedom to operate. Our group also has deep experience in litigation, and has handled cases involving biotechnological inventions in both federal and state courts.

Stites & Harbison distinguishes itself by having ongoing relationships with intellectual property firms throughout the world. This gives our clients access to highly skilled international intellectual property counsel wherever and whenever needed.

In addition to offices in the major Southeastern cities of Atlanta, Lexington, Louisville, and Nashville, our strategically located office in Alexandria, Virginia, allows Stites & Harbison attorneys to have in-person visits with Patent Examiners at the United States Patent & Trademark Office to discuss cases and advance our clients' positions.

Examples of recent biotechnology/life sciences patents issued with Stites & Harbison patent attorneys as counsel include the following:

Biotechnology/Life Sciences is part of Stites & Harbison's larger, Intellectual Property and Technology (IPT) group, which includes more than 20 attorneys – many of whom are Registered U.S. Patent Attorneys – with experience spanning all technical disciplines. Our IPT group uses a team approach to provide clients with comprehensive intellectual property services. Our attorneys practice throughout the nation and the world in the areas of patents, trademarks, copyrights, trade secrets, licensing, computer software, e-commerce and intellectual property litigation.

Main Contacts
See more related to Biotechnology/Life Sciences
Sh Office Default Optimised
Events

Blueprints for Innovation: Intellectual Property in the Bluegrass State

Date: 4/23/25
Time: 3:00 p.m. - 5:45 p.m.

UK Gatton Student Center Ballroom 212A, 160 Avenue of Champions, Lexington, Kentucky 40508

IP attorney Mandy Wilson Decker will join a team of panelist for this event presented by UK Innovate, the Council for Innovation Promotion (C4IP) and the Kentucky Intellectual Property Alliance (KYIPA) on Tuesday, April 23rd at UK's Gatton Student Center in Ball Room 212A.

Mandy Wilson Decker April 04, 2025
Webinar Image
Events

Intellectual Property Virtual Seminar

Date: 4/21/25
Time: 10:00 a.m. - 11:30 a.m.

Virtual Event

IP attorney Terry Wright will be a speaker at this virtual seminar presented by Marshall University Technology Transfer Office on April 21, 2025.

Terry L. Wright April 02, 2025
Decker Mandy BIO
Client Alerts

USPTO’s New Continuation Fees Prompt Strategic Shifts and Raise Pendency Concerns

With the USPTO’s implementation of new fees for certain continuation patent applications, applicants now face important strategic decisions regarding the timing and management of their filings. IP attorney Mandy Decker takes a look at the new fees in this Stites & Harbison Client Alert.

by Mandy Wilson Decker March 21, 2025
Sh Office Default Optimised
Client Alerts

Securing Global Patents: U.S. "Obviousness" vs. Chinese "Inventive Step" Standards

If you or your company have developed a new technology, filing a patent application is an important step to protect your investment. However, because patent rights are territorial, it’s often necessary to file patent applications not only in the United States, but also globally. IP attorneys James Hayne takes a look at the difference between the U.S. and the Chinese systems.

by James Hayne March 17, 2025